Halia Therapeutics, Inc.

This study is testing whether an experimental drug called HT-6184 can help people with myelodysplastic syndrome (MDS) who have developed anemia that hasn't responded to standard treatments. The trial involves 37 adults with low to intermediate risk MDS who will take the drug for …

This study aimed to see if adding a new drug called ofirnoflast to the existing medication semaglutide (like Ozempic®) was better for blood sugar control and weight loss in adults with type 2 diabetes who were overweight or obese. It was designed as a 12-week trial comparing the …